Awards to the Institution
| Funding | |||
|---|---|---|---|
| Disease Team Therapy Development - Research: | Rachel Smith | Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction | $19,782,136 |
Total: $19,782,136.00 |
California Institute for Regenerative Medicine
